Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

News
12 September 2012
New & experimental HIV treatments

Long-acting fusion inhibitor albuvirtide looks promising in early studies

News
11 September 2012
Pharmaceutical industry

High-End HIV Drug Stribild To Set Gilead Sciences Apart

Editor's pick
Seeking Alpha
6 September 2012
HIV treatment for children & young people

World's first HIV/AIDS nanomedicines

Editor's pick
Hospital Pharmacy Europe
3 September 2012
Pharmaceutical industry

Quad approved in US: exorbitant cost likely to block use in Europe

Editor's pick
HIV i-Base
28 August 2012
New & experimental HIV treatments

F.D.A. Approves Once-a-Day Pill for H.I.V.

Editor's pick
New York Times
28 August 2012
New & experimental HIV treatments

Attachment inhibitor BMS-663068 does well in early study involving HIV-positive people

News
28 August 2012
The search for an HIV prevention vaccine

Drug improves vaccine response in HIV patients

Editor's pick
Imperial College London press release.
24 August 2012
Pharmaceutical industry

AIDS pill's price tag draws criticism

Editor's pick
San Francisco Chronicle
24 August 2012
Neurological & cognitive problems

Hope for patients with HIV-associated cognitive impairment

Editor's pick
EurekAlert
15 August 2012
New & experimental HIV treatments

Bionor Pharma Rises as HIV Drug Study Gets Approval

Editor's pick
Bloomberg BusinessWeek
14 August 2012
New & experimental HIV treatments

Potential anti-CXCR4 drug molecule shows enhanced anti-HIV activity

Editor's pick
Science Codex
10 August 2012
Adherence

Digital pills make their way to market

Editor's pick
Nature
2 August 2012
People with limited treatment options

Once-daily elvitegravir works as well as raltegravir at 96 weeks

News
31 July 2012
New & experimental HIV treatments

Cobicistat matches ritonavir as atazanavir booster

News
30 July 2012
The search for a cure

Latest data on HIV cure research

News
27 July 2012
New & experimental HIV treatments

Dolutegravir matches raltegravir for people starting treatment

News
27 July 2012
New & experimental HIV treatments

Pioneering study shows drug can purge dormant HIV

Editor's pick
Science Daily
25 July 2012
Vaginal rings & topical PrEP

Researchers to test monthly vaginal ring for HIV prevention

Editor's pick
Reuters
25 July 2012
New & experimental HIV treatments

Once-daily maraviroc plus boosted atazanavir promising at 96 weeks

News
25 July 2012
New & experimental HIV treatments

Similar Efficacy, Side Effects in Study of Gilead Booster Cobicistat and Norvir

Editor's pick
AIDSMeds
25 July 2012
HIV treatment for children & young people

Adolescent antiretroviral options expanding

News
25 July 2012
HIV treatment for children & young people

New antiretrovirals for infants and children still needed

News
25 July 2012
New & experimental HIV treatments

Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV

Editor's pick
Merck press release
24 July 2012